{
"raw_text": "{\n  \"base_id\": \"base_chf_0218\",\n  \"evaluation\": {\n    \"summary\": \"35-44-year-old male with heart failure with reduced ejection fraction (HFrEF) and hypertension, currently treated with lisinopril, carvedilol, and furosemide. Vital signs and labs are stable and within expected ranges, indicating controlled heart failure status.\",\n    \"assessment\": {\n      \"heart_failure_management\": \"Current regimen of ACE inhibitor (lisinopril), beta-blocker (carvedilol), and diuretic (furosemide) aligns with guideline-directed medical therapy for HFrEF.\",\n      \"vitals\": \"Blood pressure 115 mmHg systolic, heart rate 68 bpm, within normal desired range for heart failure management.\",\n      \"labs\": \"BNP at 450 pg/mL is mildly elevated, consistent with chronic heart failure; renal function is stable with creatinine 1.2 mg/dL and eGFR 65 mL/min/1.73m\u00b2; Potassium at 4.0 mEq/L is normal.\",\n      \"comorbidities\": \"Hypertension is being managed with current medications; no contraindications noted.\",\n      \"allergies\": \"Patient is allergic to latex; no apparent interactions with current care.\"\n    },\n    \"recommendations\": [\n      \"Continue current guideline-directed medical therapy with ACE inhibitor, beta-blocker, and diuretics.\",\n      \"Monitor volume status and electrolytes routinely given use of diuretics and ACE inhibitors.\",\n      \"Routine follow-up to reassess BNP, renal function, and symptom status.\",\n      \"Patient education on diet, fluid management, and importance of medication adherence.\",\n      \"Consider optimization of beta-blocker dose if clinically indicated and tolerated.\"\n    ],\n    \"disclaimer\": \"This evaluation is synthetic and for educational purposes only. Not for clinical use.\"\n  }\n}",
"model_id": "openai",
"version": "gpt-4.1-mini",
"prompt_tokens": 401,
"completion_tokens": 394,
"latency_seconds": 5.688652500015451
}